Participation of prostate apoptosis response-4 in degeneration of dopaminergic neurons in models of Parkinson's disease

Annals of Neurology

Volumn 46, Issue 4, 1999, Pages 587-597

  Duan, Wenzhen ^a,b   Zhang, Zhiming ^b   Gash, Don M ^b   Mattson, Mark P ^a,b,c  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; BRAIN PROTEIN; MITOCHONDRIAL DNA; PROSTATE APOPTOSIS RESPONSE 4 PROTEIN; ROTENONE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; FEMALE; IMMUNOHISTOCHEMISTRY; MALE; MONKEY; MOUSE; NERVE DEGENERATION; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ISOLATION; PROTEIN LOCALIZATION;

ANIMALS; APOPTOSIS REGULATORY PROTEINS; BRAIN; CARRIER PROTEINS; DOPAMINE; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MACACA MULATTA; MALE; MICE; NERVE DEGENERATION; NEURONS; PARKINSON DISEASE;

EID: 0032833041     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/1531-8249(199910)46:4<587::AID-ANA6>3.0.CO;2-M     Document Type: Article

References (67)

1. Marsden CD. Parkinson's disease. J Neurol Neurosurg Psychiatry 1994;57:672-681
2. Jenner P, Olanow CW. Understanding cell death in Parkinson's disease. Ann Neurol 1998;44(Suppl 1):S72-S84
3. Schapira AH, Gu M, Taanman JW, et al. Mitochondria in the etiology and pathogenesis of Parkinson's disease. Ann Neurol 1998;44(Suppl 1):S89-S98
4. Burke RE, Kholodilov NG. Programmed cell death: does it play a role in Parkinson's disease? Ann Neurol 1998;44(Suppl 1):S126-133
5. Dexter DT, Carter CJ, Wells FR, et al. Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. J Neurochem 1989;52:381-389
6. Alam ZI, Jenner A, Daniel SE, et al. Oxidative DNA damage in the parkinsonian brain: an apparent selective increase in 8-hydroxyguanine in substantia nigra. J Neurochem 1997;69: 1196-1203
7. Alam ZI, Daniel SE, Lees AJ, et al. A generalised increase in protein carbonyls in the brain in Parkinson's but not incidental Lewy body disease. J Neurochem 1997;69:1326-1329
8. Good PF, Hsu A, Werner P, et al. Protein nitration in Parkinson's disease. J Neuropathol Exp Neurol 1998;57:338-342
9. Yoritaka A, Hattori N, Uchida K, et al. Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease. Proc Natl Acad Sci USA 1996;93:2696-2701
10. Schapira AHV, Cooper JM, Dexter D, et al. Mitochondrial complex I deficiency in Parkinson's disease. J Neurochem 1990; 54:823-827
11. Gu M, Cooper JM, Taanman JW, Schapira AH. Mitochondrial DNA transmission of the mitochondrial defect in Parkinson's disease. Ann Neurol 1998;44:177-186
12. Langsten JW. Epidemiology versus genetics in Parkinson's disease: progress in resolving an age-old debate. Ann Neurol 1998;44(Suppl 1):S45-S52
13. Bandmann O, Marsden CD, Wood NW. Genetic aspects of Parkinson's disease. Mov Disord 1998;13:203-211
14. Schneider JS, Yuwiler A, Markham CH. Selective loss of sub-populations of ventral mesencephalic dopaminergic neurons in the monkey following exposure to MPTP. Brain Res 1987;411: 144-150
15. Moratalla R, Quinn B, DeLanney LE, et al. Differential vulnerability of primate caudate-putamen and striosome-matrix dopamine systems to the neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc Natl Acad Sci USA 1992;89:3859-3863
16. Bezard E, Dovero S, Bioulac B, Gross C. Effects of different schedules of MPTP administration on dopaminergic neurodegeneration in mice. Exp Neurol 1997;148:288-292
17. Klockgether T, Turski L, Honore T, et al. The AMPA receptor antagonist NBQX has antiparkinsonian effects in monoaminedepleted rats and MPTP-treated monkeys. Ann Neurol 1991; 30:717-723
18. Zuddas A, Oberto G, Vaglini F, et al. MK-801 prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in primates. J Neurochem 1992;59:733-739
19. Temlett JA, Landsberg JP, Watt F, Grime GW. Increased iron in the substantia nigra compacta of the MPTP-lesioned hemiparkinsonian African green monkey: evidence from proton microprobe elemental microanalysis. J Neurochem 1994;62: 134-146
20. Hantraye P, Brouillet E, Ferrante R, et al. Inhibition of neuronal nitric oxide synthase prevents MPTP-induced parkinsonism in baboons. Nat Med 1996;2:1017-1021
21. Polymeropoulos MH. Autosomal dominant Parkinson's disease and α-synuclein. Ann Neurol 1998;44(Suppl 1):S63-S64
22. Wyllie AH, Kerr JFR, Currie AR. Cell death: the significance of apoptosis. Int Rev Cytol 1990;68:251-306
23. Kroemer G, Zamzami N, Susin SA. Mitochondrial control of apoptosis. Immunol Today 1997;18:44-51
24. Miller DK. The role of the caspase family of cysteine proteases in apoptosis. Semin Immunol 1997;9:35-49
25. Mochizuki H, Goto K, Mori H, Mizuno Y. Histochemical detection of apoptosis in Parkinson's disease. J Neurol Sci 1996; 137:120-123
26. Tatton NA, Maclean-Fraser A, Tatton WG, et al. A fluorescent double-labeling method to detect and confirm apoptotic nuclei in Parkinson's disease. Ann Neurol 1998;44(Suppl 1):S142-S148
27. Tatton NA, Kish SJ. In situ detection of apoptotic nuclei in the substantia nigra compacta of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice using terminal deoxynucleotidyl transferase labelling and acridine orange staining. Neuroscience 1997;77:1037-1048
28. de la Monte SM, Sohn YK, Ganju N, Wands JR. P53- and CD95-associated apoptosis in neurodegenerative diseases. Lab Invest 1998;78:401-411
29. Hassouna I, Wickert H, Zimmermann M, Gillardon F. Increase in bax expression in substantia nigra following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treatment of mice. Neurosci Lett 1996;204:85-88
30. Du Y, Dodel RC, Bales KR, et al. Involvement of a caspase-3-like cysteine protease in 1-methyl-4-phenylpyridinium-mediated apoptosis of cultured cerebellar granule neurons. J Neurochem 1997;69:1382-1388
31. +)-induced cell death in PC12 cells inhibitory effects of several drugs. Neurochem Int 1994;25:419-424
32. Sells SF, Han S-S, Muthukkumar S, et al. Expression and function of the leucine zipper protein Par-4 in apoptosis. Mol Cell Biol 1997;17:3823-3832
33. Guo Q, Fu W, Xie J, et al. Par-4 is a mediator of neuronal degeneration associated with the pathogenesis of Alzheimer's disease. Nat Med 1998;4:957-962
34. Ovadia A, Zhang Z, Gash DM. Increased susceptibility to MPTP toxicity in middle-aged rhesus monkeys. Neurobiol Aging 1995;16:931-937
35. Gash DM, Zhang Z, Ovadia A, et al. Functional recovery in parkinsonian monkeys treated with GDNF. Nature 1996;380: 252-255
36. Zhang Z, Zhang M, Avison C, Gash DM. MPTP-induced pallidal lesions in rhesus monkeys. Exp Neurol 1999;155:140-149
37. Muthane U, Ramsay KA, Jiang H, et al. Differences in nigral neuron number and sensitivity to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57/bl and CD-1 mice. Exp Neurol 1994;126:195-204
38. Tomac A, Lindqvist E, Lin LF, et al. Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature 1995;373:335-339
39. Yang L, Matthews RT, Schulz JB, et al. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity is attenuated in mice overexpressing bcl-2. J Neurosci 1998;18:8145-8152
40. Mori S, Fujitake J, Kuno S, Sano Y. Immunohistochemical evaluation of the neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on dopaminergic nigrostriatal neurons of young adult mice using dopamine and tyrosine hydroxylase antibodies. Neurosci Lett 1988;90:57-62
41. Seaton TA, Cooper JM, Schapira AHV. Free radical scavengers protect dopaminergic cell lines from apoptosis induced by complex I inhibitors. Brain Res 1997;777:110-118
42. Kruman I, Bruce-Keller AJ, Bredesen DE, et al. Evidence that 4-hydroxynonenal mediates oxidative stress-induced neuronal apoptosis. J Neurosci 1997;17:5089-5100
43. Mattson MP, Zhang Y, Bose S. Growth factors prevent mitochondrial dysfunction, loss of calcium homeostasis and cell injury, but not ATP depletion in hippocampal neurons deprived of glucose. Exp Neurol 1993;121:1-13
44. Bindokas VP, Miller RJ. Excitotoxic degeneration is initiated at non-random sites in cultured rat cerebellar neurons. J Neurosci 1995;15:6999-7011
45. Mattson MP, Goodman Y, Luo H, et al. Activation of NF-kB protects hippocampal neurons against oxidative stress-induced apoptosis: evidence for induction of Mn-SOD and suppression of peroxynitrite production and protein tyrosine nitration. J Neurosci Res 1997;49:681-697
46. Kooy NW, Royall JA, Ischoropoulos H, Beckman JS. Peroxynitrite-mediated oxidation of dihydrorhodamine 123. Free Radic Biol Med 1994;16:149-156
47. Goodman Y, Mattson MP. Ceramide protects hippocampal neurons against excitotoxic and oxidative insults, and amyloid β-peptide toxicity. J Neurochem 1996;66:869-872
48. Imai H, Nakamura T, Endo K, Narabayashi H. Hemiparkinsonism in monkeys after unilateral caudate nucleus infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): behavior and histology. Brain Res 1988;474:327-332
49. Rozas G, Lopez-Martin E, Guerra MJ, Labandeira-Garcia JL. The overall rod performance test in the MPTP-treated-mouse model of Parkinsonism. J Neurosci Methods 1998;83:165-175
50. Tipton KF, Singer TP. Advances in our understanding of the mechanisms of the neurotoxicity of MPTP and related compounds. J Neurochem 1993;61:1191-1206
51. Shimizu S, Eguchi Y, Kamiike W, et al. Bcl-2 blocks loss of mitochondrial membrane potential while ICE inhibitors act at a different step during inhibition of death induced by respiratory chain inhibitors. Oncogene 1996;13:21-29
52. + within the monoaminergic systems of the primate brain following MPTP administration: an in vivo autoradiographic study. Neuroscience 1991;40:133-158
53. Diaz-Meco MT, Municio MM, Frutos S, et al. The product of par-4, a gene induced during apoptosis, interacts selectively with the atypical isoforms of protein kinase C. Cell 1996;86: 777-786
54. Johnstone RW, See RH, Sells SF, et al. A novel repressor, Par-4, modulates transcription and growth suppression functions of the Wilms tumor suppressor WT1. Mol Cell Biol 1996;16:6945-6956
55. Berra E, Municio MM, Sanz L, et al. Positioning atypical protein kinase C isoforms in the UV-induced apoptotic signaling cascade. Mol Cell Biol 1997;17:4346-4354
56. Puls A, Schmidt S, Grawe F, Stabel S. Interaction of protein kinase C zeta with ZIP, a novel protein kinase C-binding protein. Proc Natl Acad Sci USA 1997;94:6191-6196
57. Cohen GM. Caspases: the executioners of apoptosis. Biochem J 1997;326:1-16
58. Schulze-Osthoff K, Ferrari D, Los M, et al. Apoptosis signaling by death receptors. Eur J Biochem 1998;254:439-459
59. Williams SM, Goldman-Rakic PS. Widespread origin of the primate mesofrontal dopamine system. Cerebral Cortex 1998; 8:321-345
60. 14C]-2-deoxyglucose uptake in the MPTP-treated marmoset: relationship to locomotor activity. J Neural Transm Gen Sect 1995;101:65-82
61. Rinne JO, Rummukainen J, Paljarvi L, Rinne UK. Dementia in Parkinson's disease is related to neuronal loss in the medial substantia nigra. Ann Neurol 1989;26:47-50
62. Fernandez-Ruiz J, Doudet DJ, Aigner TG. Long-term cognitive impairment in MPTP-treated rhesus monkeys. Neuroreport 1995;7:102-104
63. Elsworth JD, Deutch AY, Redmond DE Jr, et al. MPTP-induced parkinsonism: relative changes in dopamine concentration in subregions of substantia nigra, ventral tegmental area and retrorubral field of symptomatic and asymptomatic vervet monkeys. Brain Res 1990;513:320-324
64. Bodis-Wollner I, Tagliati M. The visual system in Parkinson's disease. Adv Neurol 1993;60:390-394
65. Ghilardi MF, Chung E, Bodis-Wollner I, et al. Systemic 1-methyl,4-phenyl,1-2-3-6-tetrahydropyridine (MPTP) administration decreases retinal dopamine content in primates. Life Sci 1988;43:255-262
66. Freyaldenhoven TE, Ali SF, Schmued LC. Systemic administration of MPTP induces thalamic neuronal degeneration in mice. Brain Res 1997;759:9-17
67. Gash DM, Zhang Z, Gefhardt G. Neuroprotective and neurorestorative properties of GDNF. Ann Neurol 1998;44(Suppl 1): S121-S125